Heart Failure Flashcards

1
Q

Primary Cause of Heart Failure

A

Decreased cardiac output

Decreased Heart Rate

Decreased Force of Contraction of Heart
and Decreased Volume of Blood in Heart which decreases volume of blood ejected from the heart with each heart beat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of Heart Failure

A

Acute Heart Failure
-develops rapidly (hours/

  • life threatening
  • successful management by pharmacological or surgical interventions

Chronic Heart Failure
- long term condition (months/

  • associated with adaptive changes in the heart
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Compensatory Mechanisms to Restore Cardiac Output

In Chronic Heart Failure

A

Increased Sympathetic Activity
- increased heart rate

  • increased force of contraction

Increased Renin Angiotensin Aldosterone System
lead to retention of water and salt ( in kidney lead to increased volume of blood returning to the heart

both lead to constriction of blood vessel
increased arterial blood pressure
increased resistance to blood flow
decreased cardiac output !

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Characteristics of Chronic Heart Failure

A
Increased Sympathetic Activity
-lead to heart rate and force of contraction of heart
\+ constriction of blood vessels
which lead to increased cardiac workload
then lead to myocardial hypertrophy

Increased Renin Angiotensin Aldosterone System
lead to increased water and salt retention + constriction of blood vessels
which lead to
- myocardial hypertrophy

-oedema of peripheral tissues
eg swelling of legs and ankles
fluid in lungs increased shortness of breath)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Type and effect of Positive Inotropic Drugs

A

Positive Inotropic Drugs
- Force of Contraction of the Heart

-Cardiac Glycosides
eg digoxin

-b-Adrenoceptor Stimulants
e g dobutamine, dopamine

-Phosphodiesterase Inhibitors
e g amrinone milrinone

which three of them increased intracellular calcium concentration

-Calcium Sensitizer e g levosimendan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name of Cardiac Glycosides and mechanism of actions

A

e.g. digoxin

Inhibit Na ++/K ATPase (sodium pump)

-which increased intracellular sodium concentration

  • which lead to decreased Ca2 expulsion by Na +/Ca2+ exchanger
  • then lead to increased intracellular calcium concentration

-facilitate parasympathetic activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Characteristics of Digoxin

A

Advantages
-Anti-Arrhythmic drug

Adverse Effects
Pro-Arrhythmic
GI Disturbances
CNS Disturbances
Narrow Safety Margin
Applications
NOT 1st Line Therapy
Effect Opposed by increased K
Effect Opposed by
increased Mg 2+
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name and mechanism of actions β-Adrenoceptor Stimulants

A

e.g. dobutamine , dopamine

Activate b1-Adrenoceptor in the Heart
lead to the increased intracellular concentration of cyclic adenosine monophosphate (cAMP)
then lead to activate protein kinase A (PKA)
-which lead to increased calcium entry in cardiac cells

-then lead to increased intracellular calcium concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Characteristics of

β Adrenoceptor Stimulants

A

Advantages

  • Fast Onset
  • Short Duration of Action

Adverse Effects

  • Tachyphylaxis
  • Pro-Arrhythmic
  • Pro-Angina

Applications

Used For
Acute Heart Failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Names and mechanism of actions of Phosphodiesterase Inhibitors

A

e.g. inamrinone , milrinone

  • decreased breakdown of cAMP
    • which lead to increased PKA activation
    • then lead to increased intracellular calcium concentration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Characteristics of Phosphodiesterase Inhibitors

A

Advantages
-Vasodilator Action

Adverse Effects

  • GI Disturbances
  • Pro-Arrhythmic

Applications
-Used For Acute Heart Failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Choices of Positive Inotropic Drugs (Common properties)

A

All three has Pro-arrhythmic effects

B-adrenergic receptor stimulants and phosphodiesterase inhibitors are used for acute heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name and mechanism of actions of Calcium Sensitizers

A

e.g. levosimendan

Stabilize the Binding between Troponin C and Calcium

  • increased the affinity of troponin C for calcium
    increased sensitivity to calcium contractility WITHOUT increasing intracellular calcium concentration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Characteristics of

Levosimendan

A

Advantages

-Coronary and
systemic vasodilator

Available Formulations
-Intravenous

Adverse Effects
Headache
Hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name, Effect and Adverse efffect Inhibitors of
Renin
Angiotensin System

A

Inhibitors of
Renin Angiotensin System

Angiotensin Converting Enzyme Inhibitors
-eg captopril enalapril quinapril

Angiotensin Receptor Blockers eg losartan

Pharmacological Effects
- reduces fluid retention
lead to decreased blood volume (slightly diuretic)
which reduces oedema
- reduces vasoconstriction
which lowers peripheral vascular resistance
and then decreased cardiac workload

Adverse Effects
severe hypotension (e g in patients with fluid loss)
hyperkalemia therefore caution with K sparing diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name, effect and adverse effect of Diuretics

A

Increased Fluid Excretion
-decreased oedema especially in lungs

  • which decreases pulmonary vascular congestion
  • which increases oxygenation of blood
  • lead to improve myocardial function

Loop Diuretics
eg furosemide bumetanide

Thiazide Diuretics
-eg hydrochlorothiazide, indapamide

Potassium Sparing Diuretics
-eg amiloride, spironolactone, eplerenone

17
Q

Name, effect and adverse effect of Vasodilators (I)

A

Vasodilators (I)

Nitrovasodilators eg isosorbide dinitrate

-dilation of veins
-lead to decreased volume of blood returning to the heart
lead to decreased cardiac workload

-then lead to decreased pulmonary congestion

Hydralazine

  • dilation of arterioles
    • lead to decreased resistance to blood flowing from the heart
    • lead to decreased cardiac workload

Isosorbide Dinitrate Hydralazine
-synergistic vascular actions which decreases myocardial hypertrophy

18
Q

Name, effect and adverse effect of Vasodilators (II)

A

Synthetic Brain Natriuretic Peptide e g nesiritide

  • activates natriuretic peptide receptors
  • which activates particulate guanylyl cyclase
  • then increases cyclic guanosine monophosphate (cGMP) level
  • in vascular smooth muscle
    lead to arteriolar and venous dilation
  • which decreases systemic and pulmonary vascular resistance
  • in kidney collecting duct
    lead to inhibit cyclic nucleotide gated non-selective cation channel
    which decreases sodium reabsorption then lead to diuresis

-administered intravenously [very short half life]
therefore only used for acute heart failure

-adverse effects hypotension and risk of renal damage

19
Q

Name, effect and adverse effect of B- Blockers

A

bisoprolol , carvedilol and metoprolol

-Reversal of Potentially Harmful increased Sympathetic Activity in Chronic Heart Failure

Decreased Force of Contraction of Heart
-further decreases cardiac output

  • lead to increased risk of arrhythmia
  • therefore initiated with low doses

Hence, Improve Survival in Chronic Heart Failure

20
Q

Name, effect, adverse effect, and precautions of Ivabradine

A

Mechanism of Action
- inhibit hyperpolarization activated cyclic nucleotide gated ( channels

  • lead to selectively inhibit If current in the sinoatrial node
  • therefore decreases heart rate and hence decrease cardiac workload

Adverse Effects
- bradycardia, phosphenes atrial fibrillation

Precautions
contraindicated in patients with low heart rate 60 bpm) low blood pressure
90 50 mmHg) unstable/acute heart failure, severe hepatic impairment, or
concomitant use of strong cytochrome P 450 3 A 4 inhibitors

  • not for women who are pregnant or breast feeding
  • cautions in patients with arrhythmia or risk of arrhythmia
21
Q

Effect of Sacubitril

in combination with ARB

A
  • selectively inhibit the enzyme neprilysin (a neutral endopeptidase)
    → decreases the breakdown of vasoactive peptides
    [which are upregulated in heart failure and
    serve as counter-regulatory mechanisms (as opposed to the compensatory mechanisms)]
22
Q

Effect Adverse effect and Precautions of Valsartan/

Sacubitril (LCZ696)

A

A combination of valsartan and sacubitril in a 1 1 ratio by molecule count
→a dual angiotensin receptor neprilysin inhibitor (ARNI)
→→ inhibit the actions of angiotensin II and neprilysin

Adverse Effects
- hypotension
- angioedema [due to accumulation of bradykinin and substance P]
- hyperkalemia, renal dysfunction, harm to fetus
[adverse effects of angiotensin receptor blockers]

Precautions for the Use of LCZ 696
- not to use in combination of an angiotensin-converting enzyme inhibitor
discontinue angiotensin-converting enzyme inhibitor for at least 36 hours before
valsartan/sacubitril treatment [to reduce risk of angioedema]
- Check and correct sodium and volume depletion states before valsartan/sacubitril
treatment [to minimize hypotensive effects]